169 related articles for article (PubMed ID: 817771)
21. Effect of Tdap upon antibody response to meningococcal polysaccharide when administered before, with or after the quadrivalent meningococcal TT-conjugate vaccine (coadministered with the 13-valent pneumococcal CRM197-conjugate vaccine) in adult Hajj pilgrims: A randomised controlled trial.
Tashani M; Alfelali M; Barasheed O; Alqahtani AS; Heron L; Wong M; Rashid H; Findlow H; Borrow R; Booy R
Vaccine; 2018 Jul; 36(29):4375-4382. PubMed ID: 29880243
[TBL] [Abstract][Full Text] [Related]
22. The capsular polysaccharide of group B Neisseria meningitidis as a vehicle for vaccine development.
Jennings HJ
Contrib Microbiol Immunol; 1989; 10():151-65. PubMed ID: 2479499
[No Abstract] [Full Text] [Related]
23. Long-term persistence of protective antibodies in Dutch adolescents following a meningococcal serogroup C tetanus booster vaccination.
van Ravenhorst MB; Marinovic AB; van der Klis FR; van Rooijen DM; van Maurik M; Stoof SP; Sanders EA; Berbers GA
Vaccine; 2016 Dec; 34(50):6309-6315. PubMed ID: 27817957
[TBL] [Abstract][Full Text] [Related]
24. [Analysis for protection rate and antibody levels of epidemic cerebrospinal meningitis among children aged between 3-23 months in Liuzhou, in 2012].
Cui XL; Wu X; Li MQ
Zhonghua Yu Fang Yi Xue Za Zhi; 2016 Dec; 50(12):1079-1083. PubMed ID: 28057112
[No Abstract] [Full Text] [Related]
25. Class-specific antibody response to group B Neisseria meningitidis capsular polysaccharide: use of polylysine precoating in an enzyme-linked immunosorbent assay.
Leinonen M; Frasch CE
Infect Immun; 1982 Dec; 38(3):1203-7. PubMed ID: 6818147
[TBL] [Abstract][Full Text] [Related]
26. Antibody response to meningococcal polysaccharides A and C in patients with complement defects.
Biselli R; Casapollo I; D'Amelio R; Salvato S; Matricardi PM; Brai M
Scand J Immunol; 1993 Jun; 37(6):644-50. PubMed ID: 8316762
[TBL] [Abstract][Full Text] [Related]
27. Antibody response to serogroup A and C meningococcal polysaccharide vaccines in infants born of mothers vaccinated during pregnancy.
McCormick JB; Gusmão HH; Nakamura S; Freire JB; Veras J; Gorman G; Feeley JC; Wingo P
J Clin Invest; 1980 May; 65(5):1141-4. PubMed ID: 6767739
[TBL] [Abstract][Full Text] [Related]
28. The immune response to the capsular polysaccharide of Neisseria meningitidis group B.
Romero JD; Outschoorn IM
Zentralbl Bakteriol; 1997 Feb; 285(3):331-40. PubMed ID: 9084108
[No Abstract] [Full Text] [Related]
29. Control of meningococcal meningitis with meningococcal vaccines.
Artenstein MS
Yale J Biol Med; 1975 Jul; 48(3):197-200. PubMed ID: 808913
[TBL] [Abstract][Full Text] [Related]
30. [Studies on serum meningococcal antibodies in patients with meningococcal meningitis and a healthy population].
Pang HM
Zhonghua Yu Fang Yi Xue Za Zhi; 1988 Jul; 22(4):233-5. PubMed ID: 3146488
[No Abstract] [Full Text] [Related]
31. MenHibrix: a new combination meningococcal vaccine for infants and toddlers.
Hale SF; Camaione L; Lomaestro BM
Ann Pharmacother; 2014 Mar; 48(3):404-11. PubMed ID: 24353263
[TBL] [Abstract][Full Text] [Related]
32. New meningococcal C polysaccharide-tetanus toxoid conjugate Physico-chemical and immunological characterization.
Cuello M; Cabrera O; Martinez I; Del Campo JM; Camaraza MA; Sotolongo F; Pérez O; Sierra G
Vaccine; 2007 Feb; 25(10):1798-805. PubMed ID: 17240485
[TBL] [Abstract][Full Text] [Related]
33. Salivary and Serum Antibody Response Against Neisseria meningitidis After Vaccination With Conjugate Polysaccharide Vaccines in Ethiopian Volunteers.
Bårnes GK; Workalemahu B; Kristiansen PA; Beyene D; Merdekios B; Fissiha P; Aseffa A; Caugant DA; Naess LM
Scand J Immunol; 2016 Aug; 84(2):118-29. PubMed ID: 27219622
[TBL] [Abstract][Full Text] [Related]
34. Single priming dose of meningococcal group C conjugate vaccine (NeisVac-C®) in infants.
Poellabauer EM; Pavlova BG; Fritsch S; Singer J; Neubauer C; Doralt J; Valenta-Singer B; Ehrlich HJ
Vaccine; 2013 Aug; 31(35):3611-6. PubMed ID: 23672977
[TBL] [Abstract][Full Text] [Related]
35. [Application of SP-RIA in the antibody surveillance and serologic diagnosis of epidemic cerebrospinal meningitis].
Chen X
Zhonghua Liu Xing Bing Xue Za Zhi; 1993 Dec; 14(6):366-70. PubMed ID: 8156584
[TBL] [Abstract][Full Text] [Related]
36. Recurrent meningococcal meningitis associated with deficiencies of C8 and anti-meningococcal antibody.
Cooke RP; Zafar M; Haeney MR
J Clin Lab Immunol; 1987 May; 23(1):53-6. PubMed ID: 3112405
[TBL] [Abstract][Full Text] [Related]
37. [Comparative study of the sensitivity and specificity of dried and liquid meningococcal erythrocyte diagnostic agents A, C and Y in a controlled trial].
Nikitiuk NM; Sumarokov AA; Nefedova LA; Pavlova LI; Kostiukova NN
Zh Mikrobiol Epidemiol Immunobiol; 1984 Aug; (8):72-6. PubMed ID: 6435359
[TBL] [Abstract][Full Text] [Related]
38. [Survey on efficacy of inoculating purified polysaccharide vaccines as an emergency measure in preventing epidemic meningitis].
Xu CH
Zhonghua Liu Xing Bing Xue Za Zhi; 1982 Dec; 3(6):328-30. PubMed ID: 6821030
[No Abstract] [Full Text] [Related]
39. Immunogenicity of O-acetyl-negative and -positive polysaccharide vaccines for infections with Neisseria meningitidis group C in infants.
Pichichero M; Anderson P; Gotschlich E; Kamm J; McMullen A; Nielsen S
J Infect Dis; 1985 Oct; 152(4):850-1. PubMed ID: 3930623
[No Abstract] [Full Text] [Related]
40. Antigenic specificity of bactericidal antibodies in antisera to Neisseria meningitidis.
Kasper DL; Winkelhake JL; Brandt BL; Artenstein MS
J Infect Dis; 1973 Apr; 127(4):378-87. PubMed ID: 4121052
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
